Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2024 Nov 28;49(11):1821-1827. doi: 10.11817/j.issn.1672-7347.2024.240375.ABSTRACTOBJECTIVES: Diabetes mellitus is closely associated with sudden sensorineural hearing loss (SSNHL), but no definitive evidence has established a causal relationship between type 1 di
J Obes. 2025 Mar 26;2025:3964619. doi: 10.1155/jobe/3964619. eCollection 2025.ABSTRACTBackground: Diabetic ketoacidosis (DKA) is a life-threatening complication commonly seen in Type 1 diabetes mellitus (T1DM) but also affects Type 2 diabetes mellitus (T2DM). Objectives: To compare the clinical pres
Diabet Med. 2025 Apr 2:e70034. doi: 10.1111/dme.70034. Online ahead of print.ABSTRACTAIMS: To investigate the effects of different subtypes of lipohypertrophy (LH) on insulin total daily dose (TDD) requirements in patients with type 1 diabetes mellitus (T1DM), and to propose subtype-specific insulin
J Eat Disord. 2025 Apr 2;13(1):58. doi: 10.1186/s40337-025-01242-w.ABSTRACTBACKGROUND: Metabolic control is of critical importance in children with Type 1 Diabetes Mellitus (T1DM) for the stabilization of blood glucose levels and long-term health outcomes. Dietary choices play an important role in g
Cardiovasc Diabetol. 2025 Apr 2;24(1):152. doi: 10.1186/s12933-025-02701-z.ABSTRACTBACKGROUND: Disruption of lipid metabolism contributes to increased cardiovascular risk in diabetes.METHODS: We evaluated the associations between serum lipidomic profile and subclinical carotid atherosclerosis (SCA)
Cardiovasc Diabetol. 2025 Apr 2;24(1):150. doi: 10.1186/s12933-025-02712-w.ABSTRACTBACKGROUND: The triglyceride-glucose (TyG) index is recognized as an indicator of insulin resistance and is linked to cardiovascular disease (CVD) in patients with type 2 diabetes. However, its utility in patients wit
Sci Rep. 2025 Apr 3;15(1):11371. doi: 10.1038/s41598-025-89288-3.ABSTRACTPrevious observational studies have suggested a potential link between Type 1 Diabetes (T1D) and site-specific cancer risk. However, the nature of this association remains uncertain due to confounding factors, reverse causation
J Autoimmun. 2025 Apr 1;153:103414. doi: 10.1016/j.jaut.2025.103414. Online ahead of print.ABSTRACTBACKGROUND: Glucagon-like peptide-1 receptor (GLP-1R) agonists are emerging with therapeutic agents for the treatment of two of the most prevalent metabolic disorders: diabetes and obesity. However, th
Front Endocrinol (Lausanne). 2025 Mar 18;16:1478139. doi: 10.3389/fendo.2025.1478139. eCollection 2025.ABSTRACTBACKGROUND: Diabetic cardiomyopathy (DC) is a serious complication in patients with type 1 diabetes mellitus and has become a growing public health problem worldwide. There is evidence that
Diabetes Technol Ther. 2025 Apr 2. doi: 10.1089/dia.2025.0068. Online ahead of print.ABSTRACTBackground: Automated insulin delivery (AID) systems improve glycemic outcomes, but the roles of user interaction and insulin pump settings in these findings remain underexplored. Objective: To investigate h
Scand J Immunol. 2025 Apr;101(4):e70015. doi: 10.1111/sji.70015.ABSTRACTAutoimmune thyroid disease (AITD) is associated with other autoimmune endocrine diseases such as type 1 diabetes (T1D) and celiac disease (CeD). Thyroid peroxidase autoantibodies (TPOA) are biomarkers of AITD but may also occur
Nat Commun. 2025 Apr 1;16(1):3124. doi: 10.1038/s41467-025-58278-4.ABSTRACTHypoglycemia is a serious and potentially life-threatening condition for people with insulin-dependent diabetes. To provide a safeguard against hypoglycemia, we introduce a "smart" microneedle (MN) patch that senses glucose l
Nutr Diabetes. 2025 Apr 1;15(1):13. doi: 10.1038/s41387-025-00368-9.ABSTRACTBACKGROUND AND AIM: Hypomagnesemia and clotting disorders have been reported among people with diabetes especially those with type 2 diabetes (T2DM). Magnesium plays a crucial role in hemostasis and hypomagnesemia was found
Front Endocrinol (Lausanne). 2025 Mar 17;16:1559363. doi: 10.3389/fendo.2025.1559363. eCollection 2025.ABSTRACTOBJECTIVE: This study analyzes the global and China trends in the prevalence, disease burden, and future projections of Type 1 Diabetic Nephropathy (T1DN) over the past three decades, provi
Front Endocrinol (Lausanne). 2025 Mar 17;16:1537860. doi: 10.3389/fendo.2025.1537860. eCollection 2025.ABSTRACTOBJECTIVE: The incidence of type 1 diabetes mellitus (T1DM) has increased worldwide, raising concerns about the intersection between T1DM and the rising prevalence of childhood obesity. Thi
ScientificWorldJournal. 2025 Mar 18;2025:8848211. doi: 10.1155/tswj/8848211. eCollection 2025.ABSTRACTBackground: Effective self-management behaviors are crucial for diabetes management. This study examines the mediating role of self-efficacy in the relationship between compliance dimensions and sel
Diabetol Int. 2025 Feb 10;16(2):427-431. doi: 10.1007/s13340-025-00795-0. eCollection 2025 Apr.ABSTRACTImmune checkpoint inhibitor (ICI)-related type 1 diabetes mellitus (T1DM) is a severe immune-related adverse event (irAE), occurring in < 1% of cases. ICI-related T1DM typically progresses more rap
Front Immunol. 2025 Mar 17;16:1542380. doi: 10.3389/fimmu.2025.1542380. eCollection 2025.ABSTRACTINTRODUCTION: Treating autoimmune diseases without nonspecific immunosuppression remains challenging. To prevent or treat these conditions through targeted immunotherapy, we developed a clinical-stage na
Diabetes Metab J. 2025 Mar 10. doi: 10.4093/dmj.2024.0544. Online ahead of print.ABSTRACTBACKGROUND: Type 1 diabetes mellitus related chronic kidney disease (T1DM-CKD) presents a global health challenge, with unclear trends and patterns among adolescents and young adults. This study analyzed the bur
BMC Med. 2025 Mar 31;23(1):189. doi: 10.1186/s12916-025-04001-5.ABSTRACTBACKGROUND: Antigen-specific immunotherapy shows potential for inducing long-term immune tolerance in type 1 diabetes (T1D), yet its clinical application is hampered by uncertainty regarding dominant epitopes. Conversely, non-an
BMC Endocr Disord. 2025 Mar 31;25(1):88. doi: 10.1186/s12902-025-01905-4.ABSTRACTBACKGROUND: Innovations in diabetes technology have consistently improved outcomes of persons with type1 diabetes (PWDs). However, the volumes of data that these technologies yield require different workflows to allevia
BMJ Open Qual. 2025 Mar 31;14(1):e003114. doi: 10.1136/bmjoq-2024-003114.ABSTRACTINTRODUCTION: Type 1 diabetes (T1D) is a chronic and costly disease that is often diagnosed in childhood. Achieving excellent glycaemic control during this period requires attention to multiple factors. Advances in tech
Eur J Pediatr. 2025 Mar 31;184(4):272. doi: 10.1007/s00431-025-06081-0.ABSTRACTEating disorders (EDs) are complex medical conditions that pose a considerable health burden for individuals with type 1 diabetes mellitus (T1DM). EDs in individuals with T1DM are linked to poor metabolic control, which h
Neurochem Res. 2025 Mar 31;50(2):132. doi: 10.1007/s11064-025-04385-z.ABSTRACTCerebral ketone bodies are crucial for understanding both physiological brain metabolism and pathological states, such as diabetic ketoacidosis (DKA). However, the metabolic consequences of elevated ketone body levels on b
